Onderneming Ampliphi Biosciences Corp Nyse
Aandelen
US03211P3010
Biotechnologie & Medisch Onderzoek
Vakgebied
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pathogen-specific Bacteriophage Therapeutics
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States and Australia
100,0
%
| 6 | 100,0 % | 5 | 100,0 % | -17,77% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Mina Pastagia
CTO | Chief Tech/Sci/R&D Officer | - | 26-10-20 |
Bryan Kadotani
PRN | Corporate Officer/Principal | - | - |
Richard Rychlik
AUD | Comptroller/Controller/Auditor | 68 | 05-09-23 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 64 | 12-02-20 | |
Joseph Patti
BRD | Director/Board Member | 60 | 09-05-19 |
Jules Haimovitz
BRD | Director/Board Member | 73 | 01-04-21 |
Odysseas Kostas
BRD | Director/Board Member | 49 | 12-02-20 |
Robin Kramer
CHM | Chairman | 58 | 08-12-20 |
Todd Peterson
BRD | Director/Board Member | 66 | 10-10-19 |
Deborah Birx
CEO | Chief Executive Officer | 68 | 11-07-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 36 154 617 | 10 746 770 ( 29,72 %) | 0 | 29,72 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+43,36% | 54,64 mld. | |
-5,31% | 39,92 mld. | |
+37,52% | 38,82 mld. | |
+14,75% | 26,86 mld. | |
-12,56% | 26,22 mld. | |
-22,45% | 18,78 mld. | |
+25,12% | 12,21 mld. | |
+0,04% | 12,16 mld. | |
+26,04% | 11,94 mld. |